Could your own tumor cells beat cancer? new trial for kids and young adults
NCT ID NCT06566092
First seen Apr 25, 2026 · Last updated Jun 15, 2026 · Updated 8 times
Summary
This early-stage study tests a treatment made from a patient's own tumor-fighting immune cells (TIL). It is for children, teenagers, and young adults (ages up to 21) with certain solid cancers that have come back or stopped responding to standard treatments. The main goal is to see if the treatment is safe and tolerable, and also to check if it can shrink tumors. About 40 participants will receive the TIL infusion and be followed for up to 2 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Colorado
Aurora, Colorado, 80045, United States
-
Johns Hopkins All Children's Hospital
St. Petersburg, Florida, 33701, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14203, United States
-
Rutgers Cancer Institute
New Brunswick, New Jersey, 08901, United States
Conditions
Explore the condition pages connected to this study.